Corlieve Therapeutics (private company)
See something wrong or missing? Let us know
Offices:Paris
Industry:BiotechHealth services
Business model:B2B
Corlieve Therapeutics develops first and best in class medicines for specific neuronal targets that have the potential to transform patients’ lives.
Investors:
we tracked 3 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Corlieve Therapeutics
Name | Criteria | |
---|---|---|
![]() |
Achilles Therapeutics
48%
|
|
![]() |
APIM Therapeutics
48%
|
|
![]() |
Aprea Therapeutics
48%
|
|
![]() |
Atai Life Sciences
48%
|
|
![]() |
Biofidelity
48%
|
|
![]() |
BoneSupport
48%
|
|
![]() |
CatalYm
48%
|
|
![]() |
Elypta
48%
|
|
![]() |
Galecto Biotech
48%
|
|
![]() |
InnovaFeed SAS
48%
|
|